MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹97 Cr | ₹300 Cr | ₹5.20 Cr | ₹144 Cr | ₹66 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹97 Cr |
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹5.20 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹66 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹97 Cr | -67.52 | |
| Mar2025 | ₹300 Cr | 5,661.50 | |
| Mar2024 | ₹5.20 Cr | -96.37 | |
| Mar2023 | ₹144 Cr | 116.39 | |
| Mar2022 | ₹66 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,170.4 Cr | -8.1% | -30.9% | 90.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -8.1% |
-30.9% |
90.8% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses